Literature DB >> 3493767

Intrinsic versus extrinsic coagulation. Kinetic considerations.

B J Warn-Cramer, S P Bajaj.   

Abstract

A study to compare the kinetics of activation of factor IX by Factor XIa/Ca2+ and by Factor VIIa/tissue factor/Ca2+ has been undertaken. When purified human proteins, detergent-extracted brain tissue factor and tritiated-activation-peptide-release assays were utilized, the kinetic constants obtained were: Km = 310 nM, kcat. = 25 min-1 for Factor XIa and Km = 210 nM, kcat. = 15 min-1 for Factor VIIa. The kinetic constants for the activation of Factor X by Factor VIIa/brain tissue factor were: Km = 205 nM, kcat. = 70 min-1. Predicted rates for the generation of Factor IXa and Factor Xa were obtained when human monocytic tumour U937 cells (source of tissue factor) and Factor VIIa were used to form the activator. In other experiments, inclusion of high-Mr kininogen did not increase the activation rates of Factor IX by Factor XIa in the presence or absence of platelets and/or denuded rabbit aorta. These kinetic data strongly indicate that both Factor XIa and Factor VIIa play physiologically significant roles in the activation of Factor IX.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3493767      PMCID: PMC1147351          DOI: 10.1042/bj2390757

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  A pathway of coagulation on endothelial cells.

Authors:  P P Nawroth; D M Stern
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

2.  Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX.

Authors:  S P Bajaj; S I Rapaport; W A Russell
Journal:  Biochemistry       Date:  1983-08-16       Impact factor: 3.162

3.  Role of human factor VIII in factor X activation.

Authors:  M B Hultin
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

4.  Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid.

Authors:  B A McMullen; K Fujikawa; W Kisiel; T Sasagawa; W N Howald; E Y Kwa; B Weinstein
Journal:  Biochemistry       Date:  1983-06-07       Impact factor: 3.162

5.  Human factor XII (Hageman factor).

Authors:  K Fujikawa; E W Davie
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Binding of human factor VII and VIIa to monocytes.

Authors:  G J Broze
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

7.  Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen.

Authors:  B N Bouma; R A Vlooswijk; J H Griffin
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

8.  Phospholipids accelerate factor IX activation by surface bound factor XIa.

Authors:  C Mannhalter; S Schiffman; E Deutsch
Journal:  Br J Haematol       Date:  1984-02       Impact factor: 6.998

9.  Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI.

Authors:  F van der Graaf; J S Greengard; B N Bouma; D M Kerbiriou; J H Griffin
Journal:  J Biol Chem       Date:  1983-08-25       Impact factor: 5.157

10.  Tissue factor-like activity of the human monocytic tumor cell line U937.

Authors:  D Hudig; S P Bajaj
Journal:  Thromb Res       Date:  1982-08-01       Impact factor: 3.944

View more
  5 in total

1.  Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.

Authors:  S G Spitzer; B J Warn-Cramer; C K Kasper; S P Bajaj
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

2.  Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease.

Authors:  M S Bajaj; S V Rana; R B Wysolmerski; S P Bajaj
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

3.  Thrombin activity propagates in space during blood coagulation as an excitation wave.

Authors:  N M Dashkevich; M V Ovanesov; A N Balandina; S S Karamzin; P I Shestakov; N P Soshitova; A A Tokarev; M A Panteleev; F I Ataullakhanov
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

4.  The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

Authors:  V J Bom; R M Bertina
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

5.  Exactin: A specific inhibitor of Factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus.

Authors:  Vallerinteavide Mavelli Girish; R Manjunatha Kini
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.